Not available
Quote | ArQule Inc. (NASDAQ:ARQL)
Last: | $ |
---|---|
Change Percent: | -1.40% |
Open: | $8.55 |
Close: | $8.46 |
High: | $8.58 |
Low: | $8.30 |
Volume: | 1,104,550 |
Last Trade Date Time: | 10/15/2019 07:26:54 am |
News | ArQule Inc. (NASDAQ:ARQL)
What stock will go up the most in 2020? We'd all like to know that one. And it's a question that's a lot easier to ask than to answer. Let's start by looking at the top 10 stocks of 2019 for clues. The No. 1 stock of 2019, Axsome Therapeutics , had a staggering 3,578% retu...
Co-produced with Treading Softly Here at High Dividend Opportunities we love to embrace change. Change often is driven by time, as time seems to necessitate change. For many, the change to retirement, from having worked daily, forces a change in perspective on their investing. When r...
Message Board Posts | ArQule Inc. (NASDAQ:ARQL)
Subject | By | Source | When |
---|---|---|---|
Thanks...I got it as a recommendation from a | Tempy | investorshub | 01/10/2020 3:39:59 PM |
Wow! Awesome Job and Congratulations!! I love hearing | DTGoody | investorshub | 01/10/2020 3:08:21 PM |
Good luck man...I didnt buy options here. I | Tempy | investorshub | 01/10/2020 2:20:21 PM |
I'm hoping there is a 2nd $ARQL Bidder | DTGoody | investorshub | 01/10/2020 1:29:51 PM |
You were right...the bid expires on January 15th | Tempy | investorshub | 01/10/2020 12:48:23 PM |
What stock will go up the most in 2020? We'd all like to know that one. And it's a question that's a lot easier to ask than to answer. Let's start by looking at the top 10 stocks of 2019 for clues. The No. 1 stock of 2019, Axsome Therapeutics , had a staggering 3,578% retu...
Dollar Tree (NASDAQ: DLTR) stock was pummeled in November after its earnings report resulted in the deep discounter reducing its sales outlook for the third consecutive quarter and lowering its profit forecast. Shares trade at the same level now as they did a year ago, meaning inves...
The top 10 stocks of 2019 are an interesting group. You might think tech stocks would dominate the upper echelon of equities, but you'd be wrong. As we saw in the IPO market , individual healthcare stocks actually had the strongest returns last year. Seven biotech companies made our list, inc...